Deep Vein Thrombosis Market Size Projected To Increase From $1.13 Billion To $1.36 Billion During The Forecast Period
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Deep Vein Thrombosis Market Value Expansion And Long-Term Growth Outlook
The deep vein thrombosis market has shown consistent expansion in recent times. By 2025, its valuation is projected to reach $1.09 billion, and it is expected to climb to $1.14 billion in 2026, reflecting a compound annual growth rate of 4.0%. This upward trend in the historical phase has been driven by a rise in venous thromboembolism cases, an older population engaging in more sedentary habits, an increase in surgical procedures performed within hospitals, broader access to standard anticoagulant treatments, and greater public understanding of the risks associated with DVT.
The deep vein thrombosis market is anticipated to register consistent expansion over the coming years. By 2030, it is projected to reach a valuation of $1.37 billion, reflecting a compound annual growth rate (CAGR) of 4.7%. This forecasted growth is driven by progress in novel anticoagulant therapies, a rising preference for oral medications over injectable options, the expansion of homecare and remote monitoring services, the strengthening of preventive screening initiatives, and enhanced accessibility through online pharmacies. Key trends shaping the forecast period encompass the increasing uptake of direct oral anticoagulants, a transition toward outpatient and home-based management of DVT, a stronger emphasis on early detection and risk assessment, a growing application of minimally invasive interventional techniques, and the broadening of online and specialty pharmacy networks.
Download A Free Sample Report For Comprehensive Market Insights:
Deep Vein Thrombosis Market Industry Drivers: What Is Driving Revenue Growth?
A growing number of people in need of deep vein thrombosis (DVT) care is anticipated to boost the expansion of the deep vein thrombosis market in the coming period. DVT treatment involves managing patients with this condition through medications like anticoagulants, which help stop the formation of new clots and prevent existing ones from enlarging, thereby easing the disease’s impact. The rising count of patients seeking DVT therapy points to an increased prevalence of deep vein thrombosis, creating demand for products aimed at diagnosis, prevention, and treatment. As an illustration, in February 2023, the Centers for Disease Control and Prevention (CDC), a national public health body based in the United States, reported that each year, around 900,000 individuals in the U.S. may be impacted by deep vein thrombosis, and between 60,000 and 100,000 Americans die annually from DVT or pulmonary embolism (PE). Consequently, the market is being propelled by the growing number of people requiring treatment for deep vein thrombosis (DVT).
Deep Vein Thrombosis Market Segmentation: How Is The Market Structured Across Key Categories?
The deep vein thrombosis market covered in this report is segmented –
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
Subsegments:
1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin
2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems
3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy
Deep Vein Thrombosis Market Growth Trends: What Is Influencing The Future Outlook?
Major players in the deep vein thrombosis market are increasingly turning to strategic alliances as a way to accelerate the diagnosis of DVT and boost their earnings. These partnerships highlight a growing emphasis on utilizing artificial intelligence and machine learning to enhance medical diagnostics, specifically for swift and accurate DVT identification. A notable example occurred in November 2023, when ThinkSono Ltd., a UK-based ultrasound AI firm specializing in DVT diagnosis, joined forces with NYU Langone Health, an American academic medical center. Together, they launched the first clinical trial for a novel AI-driven ultrasound software designed to facilitate faster, more portable DVT detection. Through this collaboration, the ThinkSono Guidance System harnesses AI capabilities to potentially identify DVT with greater speed, precision, and cost-effectiveness than traditional methods. During the trial, researchers will apply the ThinkSono Guidance System alongside standard ultrasound scanning in both DVT-positive and DVT-negative patients. The accuracy of the ThinkSono system will be assessed by comparing the outcomes of these two diagnostic approaches. Additionally, medical students from the NYU Grossman School of Medicine will participate in conducting the trial as part of their practical training curriculum.
Deep Vein Thrombosis Market Competitive Landscape And Leading Companies
Major companies operating in the deep vein thrombosis market are Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd., Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Shire Pharmaceuticals, AstraZeneca PLC, Endo International plc
Access The Complete Deep Vein Thrombosis Market Report:
Deep Vein Thrombosis Market Geographic Distribution And Regional Opportunities
North America was the largest region in the deep vein thrombosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
